Contact Us | Print Page | Sign In | Register
News & Press: Industry News for MS (INforMS)

CMSC INforMS: Early treatment of multiple sclerosis (MS) symptoms extends diagnosis time

Sunday, August 14, 2016  
Posted by: Elizabeth Porco
Share |

Beginning multiple sclerosis (MS) treatment at the early stage of symptoms may delay the time period in which the disease becomes definitely diagnosed or a relapse. The study found that those who received early treatment intervention were one-third less likely to be diagnosed with multiple sclerosis compared to those where treatment was delayed. Early symptoms include numbness and vision or balance problems.

Furthermore those in the early treatment group also experienced 19 percent lower annual relapse rate.

Dr. Ludwig Kappos, researcher, said, “The surprise is that after 11 years, we were still able to detect a difference favoring early treatment, although the delay in starting treatment in the delayed treatment group was only 1.5 years on average. The most astonishing observation was that relapse rates remained lower in most of the years after both groups had equal access to treatment.”

Roughly 85 percent of those who experience early multiple sclerosis symptoms will go on to be diagnosed with multiple sclerosis.

For the study there were 167 patients who received early treatment and 111 who received delayed treatment. Those who received early treatment were 33 percent less likely to be diagnosed with MS and also went longer periods without experiencing a relapse compared to those in the delayed treatment group.

The findings of the study suggest that treatment for multiple sclerosis should begin as soon as symptoms become present in order to delay diagnosis along with relapse.

By Emily Lunardo

Bel Marra Health 

CMSC Disclaimer 
The industry news information and articles are for informational purposes only, and are not intended to represent any trends, partnerships, commitments, or research of the Consortium of MS Centers or any of it's members in any way whatsoever, nor should any party be libel in any way to the reader or to any other person, firm or corporation reading this industry news section. Although the CMSC site includes links providing direct access to other Internet sites, CMSC takes no responsibility for the content or information contained on those other sites, and does not exert any editorial or other control over those other sites. CMSC is providing information and services on the Internet as a benefit and service in furtherance of CMSC's nonprofit and tax-exempt status. CMSC makes no representations about the suitability of this information and these services for any purpose.

The Consortium of Multiple Sclerosis Centers

3 University Plaza Drive, Suite 116 Hackensack, NJ 07601

Tel: 201.487.1050 | Fax: 862.772.7275